We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Soy Protein and Recurrence of Prostate Cancer

Mark A. Moyad, MD, MPH1
[+] Author Affiliations
1Department of Urology, University of Michigan Medical Center, Ann Arbor
JAMA. 2013;310(21):2311-2312. doi:10.1001/jama.2013.278601.
Text Size: A A A
Published online


To the Editor Dr Bosland and colleagues1 found no effect of a soy protein isolate on biochemical recurrence of prostate cancer. I believe there were problems with the choice of both the intervention and placebo products.

The soy isolate was not a true isolate because this would imply a concentrated protein source with minimal additive ingredients. However, the soy isolate also contained sugar (20 g per serving) and participants were encouraged to consume this product with water or fruit juice, which could impede any metabolic advantages of the intervention. Information should have been provided on whether the soy isolate reduced body weight, waist circumference, blood glucose, blood pressure, or cholesterol or testosterone compared with the placebo, as might be expected with a beneficial intervention. These cardiovascular and metabolic parameters have been linked either independently or synergistically with a lower risk and progression of prostate cancer.2


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




December 4, 2013
Maarten C. Bosland, DVSc, PhD; Ikuko Kato, MD, PhD; Anne Zeleniuch-Jacquotte, MS, MD
1Department of Pathology, University of Illinois College of Medicine, Chicago
2Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan
3Department of Population Health, New York University School of Medicine, New York
JAMA. 2013;310(21):2312-2313. doi:10.1001/jama.2013.278613.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...